To determine your company’s value in an M&A deal, you need to apply one or more recognised valuation methods, most commonly EBITDA multiples, discounted cash flow analysis, or comparable transaction benchmarks, and then adjust for deal-specific factors like risk, growth potential, and financial quality. The result is rarely a single number; it’s a range that gets tested and refined throughout the deal process. The sections below break down the key questions every founder or CFO should understand before entering a transaction.
What methods are used to value a company in an M&A deal?
The three most widely used valuation methods in M&A are the EBITDA multiple approach, discounted cash flow (DCF) analysis, and comparable transaction analysis. Each method produces a different perspective on value, and experienced advisors typically use all three to triangulate a defensible valuation range rather than relying on any single figure.
Here is how each method works in practice:
- EBITDA multiples: The company’s earnings before interest, taxes, depreciation, and amortisation are multiplied by a sector-specific benchmark. This is the most common starting point in mid-market M&A because it is simple, comparable, and easy to stress-test.
- Discounted cash flow (DCF): Future free cash flows are projected and discounted back to their present value using a risk-adjusted rate. DCF is more precise but highly sensitive to assumptions about growth and discount rates, making it useful for validation rather than as a standalone method.
- Comparable transactions: Recent deals involving similar companies in the same sector are used as reference points. This anchors the valuation in market reality and is particularly useful when negotiating price with a buyer or investor.
The method that carries the most weight depends on your industry, the quality of your financial data, and the type of buyer. Strategic buyers often pay more than financial buyers because they value synergies that a pure financial model would not capture. Understanding which method a counterparty is likely to use gives you a significant advantage at the negotiating table.
How does EBITDA affect your company’s valuation multiple?
EBITDA is the single most influential metric in determining your valuation multiple in most M&A transactions. Buyers use it as a proxy for operating profitability and cash generation capacity. The higher and more consistent your EBITDA, the stronger the multiple you can justify, but the quality and sustainability of that EBITDA matters just as much as the number itself.
A few dynamics are worth understanding:
- Size matters: Larger EBITDA figures typically attract higher multiples because they signal scale, reduced dependency on individual customers or staff, and greater resilience.
- Consistency matters: A company with stable, recurring EBITDA over three or more years commands a premium over one with volatile or one-off earnings.
- Adjustments are scrutinised: Sellers often present “adjusted” or “normalised” EBITDA that strips out exceptional costs. Buyers will challenge every adjustment, so these need to be clearly documented and defensible.
- Sector benchmarks vary widely: A software business might achieve a multiple of 8 to 12 times EBITDA, while a traditional manufacturing company may see multiples of 4 to 6. Knowing your sector’s range sets realistic expectations.
The practical implication is that improving EBITDA in the 12 to 24 months before a transaction, and making sure that improvement is well documented, can have a disproportionate impact on the final deal price.
What factors can increase or decrease your valuation in a deal?
Beyond the core financials, a range of qualitative and structural factors push your valuation up or down. Buyers are pricing risk as much as they are pricing performance, so anything that increases uncertainty will compress the multiple they are willing to pay.
Factors that increase valuation
- Recurring or contracted revenue that reduces income uncertainty
- Strong market position or defensible competitive advantage
- A capable management team that will remain post-deal
- Clean, well-organised financial records and reporting systems
- Diversified customer base with no single customer representing an outsized share of revenue
- Clear growth runway supported by market data or a proven expansion model
Factors that decrease valuation
- Customer concentration risk, one or two clients generating the majority of revenue
- Key-person dependency, particularly when the founder is deeply embedded in operations
- Weak or unreliable financial reporting that makes validation difficult
- Pending legal, tax, or regulatory issues that create contingent liabilities
- Declining margins or revenue trends that require explanation
- Outdated technology or infrastructure that a buyer would need to replace
The important insight here is that many of these factors are addressable before a deal process begins. Preparing your business for a transaction, sometimes called deal readiness, is one of the highest-return activities a company can invest in ahead of an exit or fundraising event. Our expert M&A advisory services are designed to help companies address exactly these factors before entering a process.
What’s the difference between enterprise value and equity value?
Enterprise value (EV) is the total value of the business, including debt. Equity value is what shareholders actually receive after debt is repaid. The relationship between them is straightforward: equity value equals enterprise value minus net debt (debt minus cash). In practice, this distinction has a significant impact on what a seller walks away with.
For example, if a business is valued at an enterprise value of €10 million but carries €2 million in net debt, the equity value, and therefore the seller’s proceeds, is €8 million. This is why buyers and sellers sometimes appear to agree on a headline price but then disagree on the actual payment: they may be talking about different things.
A few additional points that often cause confusion:
- Working capital adjustments: Most deals include a mechanism to adjust the final payment based on the level of working capital at closing compared to an agreed target. This can shift the effective equity value by hundreds of thousands of euros.
- Earn-outs: Part of the equity value is sometimes deferred and tied to future performance, which means the total proceeds depend on what happens after the deal closes.
- Debt-like items: Pension liabilities, deferred revenue, or certain lease obligations may be treated as debt in the calculation even if they do not appear on the balance sheet as formal loans.
Understanding the bridge from enterprise value to equity value before entering negotiations prevents unpleasant surprises at the closing table.
How does due diligence change the agreed valuation?
Due diligence frequently results in a downward adjustment to the initially agreed valuation. When a buyer’s team examines your financials, contracts, and operations in detail, they often uncover risks or discrepancies that were not visible at the headline level. These findings give them grounds to renegotiate price, adjust deal structure, or introduce price protection mechanisms.
Common due diligence findings that affect valuation include:
- Overstated or non-recurring revenue that inflates the EBITDA used to set the initial price
- Hidden liabilities such as tax exposures, customer claims, or environmental obligations
- Weaker-than-reported cash flow once working capital movements are properly accounted for
- Contractual risks in customer or supplier agreements, such as change-of-control clauses
- Gaps in financial reporting quality that reduce the buyer’s confidence in the numbers
The best way to protect your valuation through due diligence is to conduct a thorough internal review before the process begins. Sellers who understand their own risks in advance can address them proactively, present them transparently, or at minimum avoid being caught off guard. A buyer who discovers a problem themselves will price it more aggressively than one who is told about it upfront.
When should you bring in an external financial advisor for valuation?
You should bring in an external financial advisor as early as possible, ideally before you begin any formal deal process. Valuation is not just a number you arrive at at the end of a negotiation; it shapes your entire strategy, from how you position the business to which buyers you approach and what deal structure you will accept.
Specific situations where external advice is essential include:
- You are preparing for an exit and want to understand what your business is worth before approaching buyers
- You have received an unsolicited offer and need an independent view on whether the price is fair
- You are acquiring another company and need to validate the target’s valuation claims
- You are entering a funding round and need to establish a credible valuation for investor negotiations
- Your internal finance team does not have direct M&A experience and cannot objectively stress-test assumptions
The risk of going into a deal without independent financial guidance is not just overpaying or underselling. It is making a decision based on assumptions that have never been properly challenged. A good advisor does not just confirm what you want to hear, they test the investment thesis, identify what could go wrong, and help you make a decision you can stand behind.
How Greyt helps with M&A valuation and deal preparation
We guide companies through the full M&A process from a CFO perspective, which means our focus is always on whether a deal should happen, not just whether it can. Our starting point is always disciplined financial analysis, not deal momentum.
Here is what working with us on an M&A transaction looks like in practice:
- Finance Maturity Assessment: Before any deal process begins, we establish a factual baseline of your financial quality, reporting reliability, and deal readiness, so you know exactly where you stand and what to address first.
- Valuation framework: We build a credible, defensible valuation range using the right combination of methods for your sector and situation, and we stress-test the assumptions behind it.
- Independent validation: We challenge the numbers, both yours and the counterparty’s, to surface risks before they surface in due diligence and cost you money.
- Deal execution support: From structuring and negotiation through to closing, we manage the financial side of the transaction so you can stay focused on running the business.
- Post-deal integration: We stay involved after closing to ensure the value the deal was supposed to create is actually realised in the months that follow.
Whether you are preparing for an exit, evaluating an acquisition, or navigating an investor process, we bring the financial leadership and M&A experience to help you make the right call. Get in touch to talk through your situation and find out how we can support your next transaction.
Frequently Asked Questions
How long does it typically take to prepare a business for an M&A valuation process?
Meaningful deal preparation typically takes 12 to 24 months if done properly. This timeframe allows you to improve and stabilise EBITDA, clean up financial reporting, address customer concentration issues, and reduce key-person dependencies — all of which directly influence the multiple a buyer will pay. Rushing this preparation, or skipping it entirely, is one of the most common reasons sellers leave significant value on the table.
What is a normalised EBITDA and why does it matter so much to buyers?
Normalised EBITDA is your reported EBITDA adjusted to remove one-off, non-recurring, or owner-specific costs that would not continue under new ownership — such as above-market founder salaries, one-time legal fees, or exceptional restructuring costs. It matters because it forms the base number that gets multiplied to arrive at your enterprise value, so even a small, well-justified adjustment can meaningfully shift the headline price. However, every adjustment must be clearly documented and commercially defensible, as buyers will scrutinise each one during due diligence.
Can a strategic buyer really pay significantly more than a financial buyer, and why?
Yes — strategic buyers can and often do pay a meaningful premium, sometimes 20–40% more than a financial buyer would for the same business. This is because they can justify paying for synergies: cost savings from combining operations, cross-selling opportunities, or the elimination of a competitor. A financial buyer, such as a private equity firm, is constrained by the standalone returns the business can generate, whereas a strategic buyer is pricing what the business is worth inside their existing platform.
What is a working capital peg and how can it affect the final amount I receive at closing?
A working capital peg is an agreed target level of net working capital (typically current assets minus current liabilities) that is expected to be in the business at the point of closing. If the actual working capital at closing is above the peg, the buyer pays more; if it falls below, the seller receives less. This mechanism can shift the final proceeds by hundreds of thousands of euros, so it is critical to understand and negotiate the peg carefully before signing — ideally with the support of an advisor who has seen how buyers typically set these targets.
What is a common mistake founders make when they receive an unsolicited acquisition offer?
The most common mistake is engaging seriously with a single buyer without first obtaining an independent valuation or running any form of competitive process. A lone buyer has no incentive to offer full value, and without a benchmark or alternative interest, you have very little negotiating leverage. Even if you ultimately sell to that buyer, taking the time to get an independent view and, where possible, signalling that other parties exist, almost always results in better price and terms.
How do earn-outs work, and when should I be cautious about accepting one?
An earn-out is a deferred payment mechanism where part of the purchase price is paid after closing, contingent on the business hitting agreed financial or operational targets — typically over one to three years. They are often proposed when a buyer and seller disagree on future performance, allowing both sides to bridge the valuation gap. However, earn-outs carry real risk for sellers: once you lose operational control post-closing, hitting those targets may depend on decisions the new owner makes, so the metrics, governance rights, and definitions must be negotiated with great care.
Is it possible to improve my valuation multiple even if I can't significantly grow revenue before a sale?
Absolutely — multiple expansion is not solely driven by revenue growth. Improving the quality and predictability of your existing revenue (for example, by shifting customers to recurring contracts), reducing customer concentration, strengthening your management team, and upgrading your financial reporting can all increase the multiple a buyer is willing to apply, even if the top-line number stays flat. Buyers pay for certainty as much as growth, so reducing perceived risk is one of the most effective and underutilised levers available to sellers in the 12–24 months before a transaction.